Supplemental material
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 8: 50th year of the DMDG
Open access
1,377
Views
1
CrossRef citations to date
0
Altmetric
Research Articles
The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652
Anna Kerinsa Cyprotex Discovery, Macclesfield, UKhttps://orcid.org/0000-0001-7851-7542
, Marta Koszyczareka Cyprotex Discovery, Macclesfield, UKhttps://orcid.org/0000-0003-4322-3338
, Caroline Smitha Cyprotex Discovery, Macclesfield, UK
, Phil Butlera Cyprotex Discovery, Macclesfield, UKhttps://orcid.org/0000-0003-0449-4987
, Rob Rileya Cyprotex Discovery, Macclesfield, UK
, Vamsi Madgulab DMPK and Toxicology, Sai Life Sciences Limited, Hyderabad, India
, Nilkanth Naikb DMPK and Toxicology, Sai Life Sciences Limited, Hyderabad, India
, Matthew R. Redinboc Departments of Chemistry, Biochemistry & Biophysics, and Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAhttps://orcid.org/0000-0003-0814-5346
& Ian D. Wilsond Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-8558-7394
show allhttps://orcid.org/0000-0002-8558-7394
Pages 904-915
|
Received 29 Jul 2022, Accepted 21 Sep 2022, Published online: 20 Dec 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.